EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 3.0

RNA Editing Enzyme ADAR1 Suppresses the Mobility of Cancer Cells via ARPIN

Min Ji Park iD, Eunji Jeong iD, Eun Ji Lee iD, Hyeon Ji Choi iD, Bo Hyun Moon iD, Keunsoo Kang iD, Suhwan Chang

Molecules and Cells · 2023

DOI: 10.14348/molcells.2023.2174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules and Cells, 2023. Verfasst von Min Ji Park und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea. Hauptthemen laut MEDLINE: Adenosine Deaminase, MicroRNAs, Neoplasms, Carrier Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 3.0). Gefördert von: National Research Foundation of Korea, Ministry of Health & Welfare, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deamination of adenine or cytosine in RNA, called RNA editing, is a constitutively active and common modification. The primary role of RNA editing is tagging RNA right after its synthesis so that the endogenous RNA is recognized as self and distinguished from exogenous RNA, such as viral RNA. In addition to this primary function, the direct or indirect effects on gene expression can be utilized in cancer where a high level of RNA editing activity persists. This report identified actin-related protein 2/3 complex inhibitor (ARPIN) as a target of ADAR1 in breast cancer cells. Our comparative RNA sequencing analysis in MCF7 cells revealed that the expression of ARPIN was decreased upon ADAR1 depletion with altered editing on its 3'UTR. However, the expression changes of ARPIN were not dependent on 3'UTR editing but relied on three microRNAs acting on ARPIN. As a result, we found that the migration and invasion of cancer cells were profoundly increased by ADAR1 depletion, and this cellular phenotype was reversed by the exogenous ARPIN expression. Altogether, our data suggest that ADAR1 suppresses breast cancer cell mobility via the upregulation of ARPIN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenosine DeaminaseMicroRNAsNeoplasmsCarrier Proteins3' Untranslated RegionsRNA EditingRNA-Binding ProteinsHumansCell Line, Tumor

Stichwörter der Autor:innen

ADAR1ARPINRNA editingbreast cancermetastasis

Substanzen

3' Untranslated RegionsAdenosine DeaminaseMicroRNAsRNA-Binding ProteinsADAR protein, humanarpin protein, humanCarrier Proteins

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.
  • Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.
  • Department of Microbiology, College of Science & Technology, Dankook University, Cheonan 31116, Korea.
  • Department of Physiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.

ORCID-Profile: Min Ji Park, Eunji Jeong, Eun Ji Lee, Hyeon Ji Choi, Bo Hyun Moon, Keunsoo Kang

Förderung

  • National Research Foundation of Korea
  • Ministry of Health & Welfare, Republic of Korea

Zitieren

APA

Park, M. J., Jeong, E., Lee, E. J., Choi, H. J., Moon, B. H., Kang, K., & Chang, S. (2023). RNA Editing Enzyme ADAR1 Suppresses the Mobility of Cancer Cells via ARPIN. Molecules and Cells. https://doi.org/10.14348/molcells.2023.2174

Vancouver

Park MJ, Jeong E, Lee EJ, Choi HJ, Moon BH, Kang K, et al. RNA Editing Enzyme ADAR1 Suppresses the Mobility of Cancer Cells via ARPIN. Molecules and Cells. 2023. doi:10.14348/molcells.2023.2174

BibTeX
@article{Park2023,
  author = {Park, Min Ji and Jeong, Eunji and Lee, Eun Ji and Choi, Hyeon Ji and Moon, Bo Hyun and Kang, Keunsoo and Chang, Suhwan},
  title = {RNA Editing Enzyme ADAR1 Suppresses the Mobility of Cancer Cells via ARPIN},
  journal = {Molecules and Cells},
  year = {2023},
  doi = {10.14348/molcells.2023.2174}
}
Kostenlos starten →